Abstract

Background: Calcific aortic valve disease (CAVD) is a frequent cardiac pathology but still not fully understood. Novel three-dimensional (3D) models containing both valvular interstitial cells (VIC) and valvular endothelial cells (VEC) are urgently needed to investigate the complex cellular mechanisms involved in the pathogenesis of CAVD. 3D-bioprinting can offer new possibilities by designing 3D scaffolds and combining conventional cell culture methods with tissue engineering principles.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call